Job Description

Reporting to Sridhar Vasudevan you will become an integral part of an interdisciplinary team working on elucidating the interplay between sleep and neurodegeneration pathways to uncover potential novel neuroprotective strategies.
You will utilise in vivo rodent models of neurodegeneration in combination with sleep/circadian clock modulators to develop an in-depth understanding of consequences of circadian rhythms and sleep disturbance on the patho-physiology of neurodegenerative disorders.
This work is part of a collaborative project between researchers from Oxford, Circadian Therapeutics and the Michael J Fox Foundation. You will be a key member of the Oxford arm, coordinating in vivo behavioural studies between the labs of Professors Russell Foster, Aarti Jagannath and Sridhar Vasudevan, whilst also fostering and maintaining collaborations.
You should have:

• Demonstrable experience in publishing, including at least one first-author research paper and presenting research findings at meetings/conferences.
• You must hold a relevant PhD/DPhil in Pharmacology or neuroscience (or be close to completion) with experience in conducting in vivo mouse behavioural experiments.
• Knowledge, experience, and technical proficiency in working with rodent animal models, with a good working knowledge of ASPA [Animals (Scientific Procedures Act) 1986] and in possession of a personal home office license.
• Familiarity with standard techniques in immunohistochemistry, cell biology, molecular biology and biochemistry.
• Ability to manage own academic research and associated activities.
• Experience of actively collaborating with external partners in the development of research programs and articles for publication.

The post is offered on part-time (50% FTE), fixed-term basis until 30 April 2027.
The closing date for applications is 12 noon on Friday 26 September 2025.
39,424 to 47,779 per annum: Research Grade 7

Skills Required